Upcoming Lecture

The Perry & Ruby Stevens Parkinson's Disease Center of Excellence

Seminar Series presents

"What Have Genetic Studies of Parkinson's Disease, Dementia with Lewy Bodies and Alzheimer's Disease taught Us?"

 
Sudha Seshadri, M.D.
Director, Glenn Biggs Institute for Alzheimer's
& Neurodegenerative Diseases
Professor of Neurology, Psychiatry and Cellualar
and Integrative Physiology
Robert R. Baker Distinguized University Chair
UT Health San Antonio
 
Professor of Neurology, Boston University School of Medicine
Senior Investigator and Director, Neurology and Neurogenetics Core
The Framingham Heart Study
 
 
Friday, November 22 at 4:00 p.m.
Networking reception to follow
*Room 409L MED*
 
 
UT Health San Antonio
7703 Floyd Curl Drive
San Antonio, TX  78229
 
 
The Parkinson's Disease Center of Excellence Lecture Series Planning Committee Members Robert Clark MD, Andrea Giuffrida PhD, and Randy Strong PhD have no relevant financial relationships with commercial interests to disclose.
 
The UT Health Long San Antonio School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The Long School of Medicine designates this live activity up to a maximum of 1.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

About Parkinson's Center of Excellence Seminar Series

The Parkinson's Center of Excellence Seminar Series is a collaborative project among: 

         

This monthly seminar series focuses on emerging advances in Parkinson's disease (PD), including both basic and translational research, novel treatment strategies, patient/caregiver issues, and community engagement/education.  Seminars will be presented by regional and national experts in PD pathogenesis and management, with an emphasis on evidence-based innovations in therapy.  Educational objectives will be defined to best meet the needs of participants, including physician providers, clinical researchers, nurses, therapists, patient advocacy groups, and other PD stakeholders.